EFFECT OF THE ANGIOTENSIN-II RECEPTOR ANTAGONIST, LOSARTAN, ON CARDIOVASCULAR HYPERTROPHY AND REACTIVITY IN GENETIC-HYPERTENSION

被引：0
作者：
ODDIE, CJ
DILLEY, RJ
KANELLAKIS, P
BOBIK, A
机构：
[1] ALFRED HOSP,ALFRED BAKER MED UNIT,MELBOURNE,VIC 3181,AUSTRALIA
[2] BAKER MED RES INST,PRAHRAN,VIC 3181,AUSTRALIA
来源：
FASEB JOURNAL | 1993年 / 7卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A654 / A654
页数：1
相关论文
共 50 条
  • [41] EVALUATION OF THE REPRODUCTIVE AND DEVELOPMENTAL TOXICITY OF THE AT(1)-SELECTIVE ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN IN RATS
    SPENCE, SG
    CUKIERSKI, MA
    MANSON, JM
    ROBERTSON, RT
    EYDELLOTH, RS
    [J]. TERATOLOGY, 1995, 51 (06) : 383 - 397
  • [42] Treatment of tumor-induced cardiovascular dysfunction with losartan, an angiotensin II receptor antagonist
    Devine, Raymond D.
    Stevens, Sarah
    Youtz, Dane
    Bicer, Sabahattin
    Clark, Yvonne
    Wold, Loren E.
    [J]. FASEB JOURNAL, 2013, 27
  • [43] CLINICAL-PHARMACOLOGY OF THE ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN POTASSIUM IN HEALTHY-SUBJECTS
    BURNIER, M
    WAEBER, B
    BRUNNER, HR
    [J]. JOURNAL OF HYPERTENSION, 1995, 13 : S23 - S28
  • [44] Losartan, an angiotensin-II receptor antagonist reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis
    Klaassen, RJL
    VanGelder, T
    RischenVos, J
    Deinum, J
    ManintVeld, AJ
    Weimar, W
    [J]. TRANSPLANTATION, 1997, 64 (05) : 780 - 782
  • [45] Angiotensin-II receptor antagonist losartan reduces micro albuminuria in hypertensive renal transplant recipients
    Ersoy, A
    Dilek, K
    Usta, M
    Yavuz, M
    Güllülü, M
    Oktay, B
    Yurtkuran, M
    [J]. CLINICAL TRANSPLANTATION, 2002, 16 (03) : 202 - 205
  • [46] Angioedema associated with angiotensin II receptor antagonist losartan
    Sharma, PK
    Yium, JJ
    [J]. SOUTHERN MEDICAL JOURNAL, 1997, 90 (05) : 552 - 553
  • [47] Angiotensin converting enzyme genotype influences the response to the angiotensin II receptor antagonist Losartan in patients with hypertension
    Nakamura, Y
    Tamaki, S
    Uchida, Y
    Ohmichi, N
    Yamaoka, O
    Miyauchi, N
    Fukuhara, T
    Sayama, H
    Yamada, T
    Matsuo, S
    Yamada, Y
    [J]. HYPERTENSION RESEARCH, 2004, 27 (03) : 137 - 140
  • [48] Cardiovascular hypertrophy in angiotensin II-induced hypertension. Influence of losartan and bosentan.
    Herizi, A
    Belabbas, H
    Mimran, A
    Jover, B
    [J]. ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2000, 93 (08): : 983 - 986
  • [49] EARLY AND LATE HEMODYNAMIC AND MORPHOLOGICAL EFFECTS OF ANGIOTENSIN-II SUBTYPE-1 RECEPTOR BLOCKADE DURING GENETIC-HYPERTENSION DEVELOPMENT
    VACHER, E
    FORNES, P
    RICHER, C
    BRUNEVAL, P
    NISATO, D
    GIUDICELLI, JF
    [J]. JOURNAL OF HYPERTENSION, 1995, 13 (06) : 675 - 682
  • [50] EFFECT OF LOSARTAN, AN AT(1) SELECTIVE ANGIOTENSIN-II RECEPTOR ANTAGONIST, ON ISOPROTERENOL-INDUCED CARDIAC ORNITHINE DECARBOXYLASE ACTIVITY
    NAKANO, M
    KANDA, T
    MATSUZAKI, S
    HASEGAWA, S
    MA, HT
    IMAI, S
    SUZUKI, T
    KOBAYASHI, I
    [J]. RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 1995, 88 (01) : 21 - 30
12345